家族史对炎症性肠病及匹配一般人群结直肠癌风险的影响
这项全国性登记队列研究纳入1996至2023年IBD患者及匹配对照,评估家族史与结直肠癌发病率的关联。IBD患者结直肠癌发病率为1.17/1000人年,对照为0.88/1000人年;有2个及以上患病亲属者绝对风险增加最大。相同家族史下IBD与对照的发病率相当,但无家族史者IBD发病率更高。
要点
- 有2个及以上患结直肠癌一级亲属的IBD患者绝对风险增加最大。
- 相同家族史下IBD与匹配对照的结直肠癌发病率相当。
- 无家族史的IBD患者结直肠癌发病率仍高于匹配对照。
核心结论
- 在绝对尺度上,结直肠癌家族史在IBD与匹配对照中相似地增加结直肠癌发病率,多个患病亲属者增加最大。
- 研究结果提出监测策略是否应优先关注有多个患病亲属的患者。
研究设计与样本
- 全国性、基于登记的队列研究,1996年至2023年,纳入IBD患者及按年龄、性别、教区、年份匹配的一般人群对照。
- 暴露为家族史,定义为一级亲属(父母、兄弟姐妹或子女)患结直肠癌的数量及其诊断年龄(<50岁或≥50岁)。
主要发现
- 中位随访11年,124,387例IBD患者发生1882例结直肠癌,发病率为1.17/1000人年(95%CI 1.12–1.23)。
- 1,213,641名匹配对照发生14,177例结直肠癌,发病率为0.88/1000人年(95%CI 0.86–0.89)。
- IBD中,2个及以上患病亲属者较无家族史者每1000人年额外增加2.69例(95%CI 0.60–4.78)。
- 早发性结直肠癌遗传的风险增加较温和,每1000人年0.42例(95%CI -0.47–1.31)。
- 相同家族史下IBD与匹配对照的发病率相当,但无家族史者IBD的结直肠癌发病率更高。
关键数值与推荐
- 指南建议特别关注有早发性结直肠癌家族史的患者。
临床怎么用
- 临床应关注IBD患者的结直肠癌家族史,尤其是有多个患病一级亲属者。
- 无家族史的IBD患者仍应重视结直肠癌监测,因其基线风险高于一般人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Few studies have explored how a family history of colorectal cancer (CRC) affects CRC incidence in inflammatory bowel disease (IBD). We estimated CRC incidence rates (IRs) and IR differences according to family history of CRC and the interaction between IBD and family history. METHODS: This was a nationwide, register-based cohort study from 1996 through 2023, including patients with IBD and matched comparators (ie, age, sex, parish, and year) from the general population. The exposure was family history, defined as the number of first-degree relatives (ie, parent, sibling, or child) and their age at CRC diagnosis (<50 years or ≥50 years). RESULTS: During a median follow-up of 11 years, 1882 CRC events occurred in 124,387 patients with IBD (IR, 1.17; 95% CI, 1.12 to 1.23 per 1000 person-years) and 14,177 CRC events in 1,213,641 comparators (IR, 0.88; 95% CI, 0.86 to 0.89 per 1000 person-years). In IBD, the greatest CRC risk increase was seen in those with 2 or more affected relatives: 2.69 (95% CI, 0.60 to 4.78) additional cases per 1000 person-years vs no family history, and the risk increase with early-onset CRC heredity was modest: 0.42 (95% CI, -0.47 to 1.31) per 1000 person-years. The IRs were comparable between patients and matched comparators with the same family history, except among those without family history of CRC, where the CRC incidence was higher in IBD. The relative effect of family history was weaker in IBD, where the baseline CRC risk was already elevated. CONCLUSIONS: On the absolute scale, family history of CRC increased CRC incidence similarly in IBD and matched comparators, with the greatest increase in individuals with multiple affected relatives. Guidelines advise special attention to patients with family history of early-onset CRC. Our findings raise the question of whether surveillance strategies should instead prioritize patients with multiple affected relatives.
引用
- Everhov ÅH, Kristjánsson K, Ludvigsson JF, et al. Impact of Family History on Colorectal Cancer Risk in Inflammatory Bowel Disease and in Matched General Population Comparators. Gastroenterology. 2026. PMID: 42692118. doi:10.1053/j.gastro.2026.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。